489 related articles for article (PubMed ID: 9209504)
1. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
2. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
Grant CF; Ali R; Povey S; Stockinger B
Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
[TBL] [Abstract][Full Text] [Related]
3. Localization of self antigen: implications for antigen presentation and induction of tolerance.
Stockinger B; Grant CF; Hausmann B
Eur J Immunol; 1993 Jan; 23(1):6-11. PubMed ID: 8419188
[TBL] [Abstract][Full Text] [Related]
4. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
5. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes.
Stockinger B
Eur J Immunol; 1992 May; 22(5):1271-8. PubMed ID: 1577067
[TBL] [Abstract][Full Text] [Related]
6. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
8. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
Volkmann A; Zal T; Stockinger B
J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
10. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
Bikoff EK
J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
[TBL] [Abstract][Full Text] [Related]
11. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
12. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
19. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.
Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]